These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24586882)

  • 1. Impact of antiretroviral therapy on renal function among HIV-infected Tanzanian adults: a retrospective cohort study.
    Mpondo BC; Kalluvya SE; Peck RN; Kabangila R; Kidenya BR; Ephraim L; Fitzgerald DW; Downs JA
    PLoS One; 2014; 9(2):e89573. PubMed ID: 24586882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal dysfunction among HIV-infected patients starting antiretroviral therapy.
    Msango L; Downs JA; Kalluvya SE; Kidenya BR; Kabangila R; Johnson WD; Fitzgerald DW; Peck RN
    AIDS; 2011 Jul; 25(11):1421-5. PubMed ID: 21572304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal impairment in HIV-infected patients initiating tenofovir-containing antiretroviral therapy regimens in a Primary Healthcare Setting in South Africa.
    Kamkuemah M; Kaplan R; Bekker LG; Little F; Myer L
    Trop Med Int Health; 2015 Apr; 20(4):518-26. PubMed ID: 25442109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glomerular dysfunction and associated risk factors over 4-5 years following antiretroviral therapy initiation in Africa.
    Stöhr W; Reid A; Walker AS; Ssali F; Munderi P; Mambule I; Kityo C; Grosskurth H; Gilks CF; Gibb DM; Hakim J;
    Antivir Ther; 2011; 16(7):1011-20. PubMed ID: 22024517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe renal dysfunction and risk factors associated with renal impairment in HIV-infected adults in Africa initiating antiretroviral therapy.
    Reid A; Stöhr W; Walker AS; Williams IG; Kityo C; Hughes P; Kambugu A; Gilks CF; Mugyenyi P; Munderi P; Hakim J; Gibb DM;
    Clin Infect Dis; 2008 Apr; 46(8):1271-81. PubMed ID: 18444867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of baseline renal function on tenofovir-containing antiretroviral therapy outcomes in Zambia.
    Mulenga L; Musonda P; Mwango A; Vinikoor MJ; Davies MA; Mweemba A; Calmy A; Stringer JS; Keiser O; Chi BH; Wandeler G;
    Clin Infect Dis; 2014 May; 58(10):1473-80. PubMed ID: 24585558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and risk factors for tenofovir-associated renal toxicity in HIV-infected patients.
    Quesada PR; Esteban LL; García JR; Sánchez RV; García TM; Alonso-Vega GG; Ferrández JS
    Int J Clin Pharm; 2015 Oct; 37(5):865-72. PubMed ID: 26008219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in the renal function after tenofovir-containing antiretroviral therapy initiation in a Senegalese cohort (ANRS 1215).
    De Beaudrap P; Diallo MB; Landman R; Guèye NF; Ndiaye I; Diouf A; Kane CT; Etard JF; Girard PM; Sow PS; Delaporte E;
    AIDS Res Hum Retroviruses; 2010 Nov; 26(11):1221-7. PubMed ID: 20854202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal dysfunction by baseline CD4 cell count in a cohort of adults starting antiretroviral treatment regardless of CD4 count in the HIV Prevention Trials Network 071 [HPTN 071; Population Effect of Antiretroviral Therapy to Reduce HIV Transmission (PopART)] study in South Africa.
    Bock P; Nel K; Fatti G; Sloot R; Ford N; Voget J; Gunst C; Grobbelaar N; Louis F; Floyd S; Hayes R; Ayles H; Beyers N; Fidler S;
    HIV Med; 2019 Jul; 20(6):392-403. PubMed ID: 30963667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The significance of antiretroviral-associated acute kidney injury in a cohort of ambulatory human immunodeficiency virus-infected patients.
    Wikman P; Safont P; Del Palacio M; Moreno A; Moreno S; Casado JL
    Nephrol Dial Transplant; 2013 Aug; 28(8):2073-81. PubMed ID: 23739150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baseline renal insufficiency and risk of death among HIV-infected adults on antiretroviral therapy in Lusaka, Zambia.
    Mulenga LB; Kruse G; Lakhi S; Cantrell RA; Reid SE; Zulu I; Stringer EM; Krishnasami Z; Mwinga A; Saag MS; Stringer JS; Chi BH
    AIDS; 2008 Sep; 22(14):1821-7. PubMed ID: 18753939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for impaired renal function in HIV-infected and HIV-uninfected adults: cross-sectional study in North-Western Tanzania.
    Kavishe BB; Kweka BV; Nitsch D; PrayGod G; Jeremiah K; Faurholt-Jepsen D; Filteau S; Olsen MF; Kitilya BW; Krogh-Madsen R; Friis H; Peck R
    BMC Nephrol; 2021 Oct; 22(1):355. PubMed ID: 34715799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of low estimated glomerular filtration rate, proteinuria, and associated risk factors among HIV-infected black patients using Cockroft-Gault and modification of diet in renal disease study equations.
    Longo AL; Lepira FB; Sumaili EK; Makulo JR; Mukumbi H; Bukabau JB; Mokoli VM; Kayembe PK; Nseka NM
    J Acquir Immune Defic Syndr; 2012 Jan; 59(1):59-64. PubMed ID: 21926635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal outcomes in patients initiated on tenofovir disoproxil fumarate-based antiretroviral therapy at a community health centre in Malawi.
    Chikwapulo B; Ngwira B; Sagno JB; Evans R
    Int J STD AIDS; 2018 Jun; 29(7):650-657. PubMed ID: 29334883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and risk factors of mild chronic renal failure in HIV-infected patients: influence of female gender and antiretroviral therapy.
    Cristelli MP; Trullàs JC; Cofán F; Rico N; Manzardo C; Ambrosioni J; Bedini JL; Moreno A; Diekmann F; Miro JM;
    Braz J Infect Dis; 2018; 22(3):193-201. PubMed ID: 29782827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal function in a cohort of HIV-infected patients initiating antiretroviral therapy in an outpatient setting in Ethiopia.
    Fiseha T; Gebreweld A
    PLoS One; 2021; 16(1):e0245500. PubMed ID: 33481839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low Incidence of Renal Dysfunction among HIV-Infected Patients on a Tenofovir-Based First Line Antiretroviral Treatment Regimen in Myanmar.
    Kyaw NT; Harries AD; Chinnakali P; Antierens A; Soe KP; Woodman M; Das M; Shetty S; Zuu MK; Htwe PS; Fernandez M
    PLoS One; 2015; 10(8):e0135188. PubMed ID: 26301416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Highly Active Antiretroviral Therapy on Albuminuria in HIVinfected Persons.
    Adedeji TA; Adebisi SA; Adedeji NO
    Infect Disord Drug Targets; 2020; 20(3):374-384. PubMed ID: 31389318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High prevalence of renal dysfunction and association with risk of death amongst HIV-infected Ghanaians.
    Sarfo FS; Keegan R; Appiah L; Shakoor S; Phillips R; Norman B; Hardy Y; Bedu-Addo G; Longstaff L; Chadwick DR
    J Infect; 2013 Jul; 67(1):43-50. PubMed ID: 23542785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertension, kidney disease, HIV and antiretroviral therapy among Tanzanian adults: a cross-sectional study.
    Peck RN; Shedafa R; Kalluvya S; Downs JA; Todd J; Suthanthiran M; Fitzgerald DW; Kataraihya JB
    BMC Med; 2014 Jul; 12():125. PubMed ID: 25070128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.